Literature DB >> 11156950

Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow.

M Ticchioni1, V Raimondi, L Lamy, J Wijdenes, F P Lindberg, E J Brown, A Bernard.   

Abstract

Integrin-associated protein (CD47/IAP) is a pentaspan molecule that regulates integrin functions. We prepared a CD47-deficient Jurkat T cell line to assess its role in the arrest of T cells on inflammatory endothelium. Under flow conditions, constitutive arrest of CD47-deficient cells is strongly decreased as compared to the original cell line, whereas reexpression of CD47 reestablishes their ability to stop. Moreover, cells transfected with a chimera made with the extracellular portion of CD47 and the transmembrane domain of CD7 or several truncated forms of CD47 show that the first transmembrane domain and a short cytoplasmic loop are sufficient for this process. CD47 effect is indirect and depends mainly on the alpha4beta1/VCAM-1 pathway, as shown by blocking antibodies. We detected on endothelium the two CD47 counter receptors known to date: thrombospondin and SIRP1alpha. Blocking experiments show that both are involved. Overall, CD47 participates in the constitutive arrest of T lymphocytes on inflamed vascular endothelium by up-regulating alpha 4beta1 integrins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156950     DOI: 10.1096/fj.99-0833com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

Review 1.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

Review 2.  Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells.

Authors:  Ronen Alon; Klaus Ley
Journal:  Curr Opin Cell Biol       Date:  2008-05-20       Impact factor: 8.382

3.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

4.  Endothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivo.

Authors:  Veronica Azcutia; Michael Stefanidakis; Naotake Tsuboi; Tanya Mayadas; Kevin J Croce; Daiju Fukuda; Masanori Aikawa; Gail Newton; Francis W Luscinskas
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

5.  Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy.

Authors:  Mark P Chao; Chad Tang; Russell K Pachynski; Robert Chin; Ravindra Majeti; Irving L Weissman
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

6.  Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; Justin B Maxhimer; Perlita Powers; Maria Tsokos; William A Frazier; David D Roberts
Journal:  Surgery       Date:  2008-09-02       Impact factor: 3.982

7.  Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro.

Authors:  Michael Stefanidakis; Gail Newton; Winston Y Lee; Charles A Parkos; Francis W Luscinskas
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

8.  Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.

Authors:  Diane Tseng; Jens-Peter Volkmer; Stephen B Willingham; Humberto Contreras-Trujillo; John W Fathman; Nathaniel B Fernhoff; Jun Seita; Matthew A Inlay; Kipp Weiskopf; Masanori Miyanishi; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

9.  Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.

Authors:  Jeff S Isenberg; Douglas S Annis; Michael L Pendrak; Malgorzata Ptaszynska; William A Frazier; Deane F Mosher; David D Roberts
Journal:  J Biol Chem       Date:  2008-11-11       Impact factor: 5.157

10.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.